1939.3000 3.70 (0.19%)
NSE Oct 10, 2025 15:31 PM
Volume: 867.4K
 

1939.30
0.19%
Ashika Research
Glenmark pharma's (GNP) Q1FY14 revenues grew 19% YoY to Rs. 1238.2 cr driven by 33% growth in Latin America (specialty business), 25% growth in RoW markets, 26% growth in API...
Number of FII/FPI investors decreased from 404 to 396 in Jun 2025 qtr
More from Glenmark Pharmaceuticals Ltd.
Recommended